# OnCo record paper-andrade-neo-real-adjuvant-safety-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-andrade-neo-real-adjuvant-safety-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-andrade-neo-real-adjuvant-safety-2026" ;
  schema:name "Neo-Real: adjuvant treatment patterns and safety after TNBC chemoimmunotherapy"@en ;
  schema:description "After chemoimmunotherapy, combinations of additional drugs were common when cancer remained at surgery. This study describes safety, not whether the combinations improve survival."@en ;
  schema:url <https://onco.cc/key-papers/paper-andrade-neo-real-adjuvant-safety-2026/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s10549-026-07938-0>, <https://pubmed.ncbi.nlm.nih.gov/41848921/> ;
  schema:sameAs <https://doi.org/10.1007/s10549-026-07938-0> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Andrade MO, Bonadio RC, Ipiña A, et al." ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/capecitabine/> .